NWM
REGN icon

Northwest Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Northwest Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-503
Closed -$389K – 288
2026
Q1 		$389K Buy
503
+29
+6% +$22.2K 0.06% 148
2025
Q4 		$366K Buy
+474
New +$322K 0.06% 160

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Northwest Wealth Management's REGN Position: Q2 2026 in Review

Northwest Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 503 shares — an estimated $389K sold.

Northwest Wealth Management first reported a position in REGN in Q4 2025 and held it in 2 quarters. The position peaked at $389K in Q1 2026. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Northwest Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Northwest Wealth Management sold 503 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $389K.
  • Northwest Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Northwest Wealth Management's Regeneron Pharmaceuticals position peaked at $389K in Q1 2026.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Northwest Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.